The Role of the Pharmacist in Optimizing Treatment Options and Monitoring Abuse in ADHD Medications

Supported by an educational grant from Mallinckrodt Pharmaceuticals.

The Role of the Pharmacist in Optimizing Treatment Options and Monitoring Abuse in ADHD Medications

Faculty

Megan J. Ehret, PharmD, MS, BCPP

Associate Professor

University of Connecticut

Storrs, CT

Educational Objectives:

After completing this continuing education program, the participant will be able to:

• List the current medications, appropriate dosing, and alternative formulations available for ADHD treatment.
• State the substance abuse landscape as it relates to ADHD.
• Review data on the pharmacist’s role as gatekeeper for ADHD medications.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

April 6, 2015

Expiration date:

April 6, 2017

Estimated time to complete activity:

2.0 hours

Fee:

Free

Pharmacy Times Office of Continuing Professional Education is accredited by the accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-028-H01-P. The activity is available for CE credit through April 6, 2017.